Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
NASDAQ:HOLX
HOLX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$62.70 - $84.67
Previous CloseN/A
Volume386.02K
Average Volume (3M)2.56M
Market Cap
$14.35B
Enterprise Value$17.42B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)20.3
Beta0.35
Next Earnings
Apr 30, 2025EPS Estimate
1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.16
Shares Outstanding224,389,620
10 Day Avg. Volume2,996,304
30 Day Avg. Volume2,556,716
Standard Deviation0.09
R-Squared0.29
Alpha-0.00244
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.55
Price to Cash Flow (P/CF)19.00
P/FCF Ratio19.70
Enterprise Value/Market Cap1.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.82
Enterprise Value/Ebitda12.97
Forecast
1Y Price Target
$83.54Price Target Upside30.12% Upside
Rating ConsensusHold
Number of Analyst Covering16
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceHOLX's gross margin was up 80 bps and its operating margin was up 90 bps.
Growth ProjectionsHOLX expects growth to improve and expects to end the year back at their mid-single digit growth target.
Strategic InitiativesThe path back to +5-7% growth could come as soon as FY:26 on a combination of core Molecular upgrades, Envision gantry uptake, & M&A upside.
Bears Say
Breast Health ChallengesThe company continues to experience a number of challenges in their Breast Health business.
Market ConditionsUS hospital capital spending is at least one trigger behind the lower-than-expected Breast Health gantry outlook.
Revenue GuidanceManagement lowered their FY25 revenue guidance but maintained their EPS guidance.
---
Ownership Overview
1.40% Insiders
30.21% Mutual Funds
21.33% Other Institutional Investors
16.87% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HOLX FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $62.70 and its highest was $84.67 in the past 12 months.
What is Hologic’s market cap?
Hologic’s market cap is $14.35B.
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Apr 30, 2025 which is in 68 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on Feb 05, 2025. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.01.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is 1.02.
How many shares outstanding does Hologic have?
Hologic has 224,389,620 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.03 in its last earnings report, beating expectations of $1.02. Following the earnings report the stock price went down -10.096%.
Which hedge fund is a major shareholder of Hologic?
Currently, no hedge funds are holding shares in HOLX
---
Hologic Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$83.54 (30.12% Upside)
$83.54 (30.12% Upside)
Blogger Sentiment
Bullish
HOLX Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.1%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.99%
12-Months-Change
Fundamentals
Return on Equity
15.78%
Trailing 12-Months
Asset Growth
3.06%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.
---
HOLX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Hologic's earnings call presented a mixed outlook. The company showed strength in its Diagnostics division and maintained strong operating margins, but faced challenges in Breast Health and Skeletal businesses, along with lowered revenue guidance. The commitment to maintaining EPS guidance despite revenue challenges highlights operational efficiency.Read More>---
HOLX Revenue Breakdown
44.22% Diagnostics
37.79% Breast Health
15.91% GYN Surgical
2.09% Skeletal Health
---
HOLX Stock 12 Month Forecast
Average Price Target
$83.54
▲(30.12% Upside)
Technical Analysis
Abbott Laboratories
―
Becton Dickinson
―
Steris
―
Thermo Fisher
―
Zimmer Biomet Holdings
―
Best Analysts Covering HOLX
1 Year
1 Year Success Rate
5/10 ratings generated profit
1 Year Average Return
+2.72%
reiterated a buy rating 16 days ago
Copying Andrew Cooper's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +2.72% per trade.
---